Stay updated on Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Version updated to v3.0.2 and the 'Back to Top' element has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:50:55.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T13:36:25.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has added significant resources related to ovarian cancer and various medical topics while removing several specific cancer-related resources and location details.
    Difference
    5%
    Check dated 2025-08-31T11:29:38.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    1.0%
    Check dated 2025-08-24T07:30:07.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:36:47.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T23:53:26.000Z thumbnail image

Stay in the know with updates to Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.